|
3CO6
Crystal Structure of FoxO1 DBD Bound to DBE1 DNA
Deposited 2008-03-27
|
Different construct
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein–DNA
Monomer;Protein × 1
PDB declaration: trimeric
|
Chain C
151–249(99 aa)
|
Not recorded
|
CL CHLORIDE ION × 1
CA CALCIUM ION × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 7.9;277 K;22% PEG 4000, pH 7.9, VAPOR DIFFUSION, HANGING DROP, temperature 277K
|
Resolution 2.10 Å
R-free 0.256
|
|
3COA
Crystal Structure of FoxO1 DBD Bound to IRE DNA
Deposited 2008-03-27
|
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein–DNA
Monomer;Protein × 1
PDB declaration: trimeric
|
Chain C
151–266(116 aa)
|
Not recorded
|
CA CALCIUM ION × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 6.8;277 K;30% PEG 4000, pH 6.8, VAPOR DIFFUSION, HANGING DROP, temperature 277K
|
Resolution 2.20 Å
R-free 0.250
|
|
3COA
Crystal Structure of FoxO1 DBD Bound to IRE DNA
Deposited 2008-03-27
|
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 2
Protein–DNA
Monomer;Protein × 1
PDB declaration: trimeric
|
Chain F
151–266(116 aa)
|
Not recorded
|
CA CALCIUM ION × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 6.8;277 K;30% PEG 4000, pH 6.8, VAPOR DIFFUSION, HANGING DROP, temperature 277K
|
Resolution 2.20 Å
R-free 0.250
|
|
4LG0
Structure of a ternary FOXO1-ETS1 DNA complex
Deposited 2013-06-27
|
Different construct
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein–DNA
Heteromer;Protein × 2
PDB declaration: tetrameric
|
Chain A
143–270(128 aa)
Fragment:DNA Binding Domain, UNP residues 143-270
|
Not recorded
|
CA CALCIUM ION × 1
PG4 TETRAETHYLENE GLYCOL × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;pH 8.5;291 K;30% PEG 400, 0.05M 2-Amino-2-hydroxymethyl-propane-1,3-diol, 0.1M potassium chloride, 0.01M magnesium chloride, pH 8.5, VAPOR DIFFUSION, SITTING DROP, temperature 291K
|
Resolution 2.19 Å
R-free 0.243
|
|
5DUI
Identification of a new FoxO1 binding site that precludes CREB binding at the glucose-6-phosphatase catalytic subunit gene promoter
Deposited 2015-09-18
|
Different construct
Different mutation/modification
Different oligomeric state
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein–DNA
Homooligomer;Protein × 2
PDB declaration: tetrameric
|
Chain A
151–259(109 aa)
Fragment:unp residues 151-259
Chain B
151–259(109 aa)
Fragment:unp residues 151-259
|
Not recorded
|
No recorded non-water small molecule
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;293 K;14-18% PEG 8000
0.1M Ammonium sulfate
20mM Magnesium chloride
50mM MES pH 5.6
10% glycerol
|
Resolution 2.31 Å
R-free 0.245
|
|
6LBI
Crystal Structure of FOXO1-DBD homodimer bound to a palindromic DNA sequence
Deposited 2019-11-14
|
Different construct
Different mutation/modification
Different oligomeric state
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein–DNA
Homooligomer;Protein × 2
PDB declaration: tetrameric
|
Chain C
151–265(115 aa)
Chain D
151–265(115 aa)
|
Not recorded
|
No recorded non-water small molecule
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;277 K;50 mM NaAc, pH 4.7, 12%-18% PEG4000 (w/v), 200 mM NaCl, 10 mM MgCl2 and 1 mM TCEP.
|
Resolution 3.07 Å
R-free 0.264
|
|
6LBI
Crystal Structure of FOXO1-DBD homodimer bound to a palindromic DNA sequence
Deposited 2019-11-14
|
Different construct
Different mutation/modification
Different oligomeric state
Different experimental conditions
Different structure-quality metrics
|
Assembly 2
Protein–DNA
Homooligomer;Protein × 2
PDB declaration: tetrameric
|
Chain G
151–265(115 aa)
Chain H
151–265(115 aa)
|
Not recorded
|
No recorded non-water small molecule
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;277 K;50 mM NaAc, pH 4.7, 12%-18% PEG4000 (w/v), 200 mM NaCl, 10 mM MgCl2 and 1 mM TCEP.
|
Resolution 3.07 Å
R-free 0.264
|
|
6LBI
Crystal Structure of FOXO1-DBD homodimer bound to a palindromic DNA sequence
Deposited 2019-11-14
|
Different construct
Different mutation/modification
Different oligomeric state
Different experimental conditions
Different structure-quality metrics
|
Assembly 3
Protein–DNA
Homooligomer;Protein × 2
PDB declaration: tetrameric
|
Chain K
151–265(115 aa)
Chain L
151–265(115 aa)
|
Not recorded
|
No recorded non-water small molecule
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;277 K;50 mM NaAc, pH 4.7, 12%-18% PEG4000 (w/v), 200 mM NaCl, 10 mM MgCl2 and 1 mM TCEP.
|
Resolution 3.07 Å
R-free 0.264
|
|
6QVW
Solution structure of the free FOXO1 DNA binding domain
Deposited 2019-03-05
|
Different construct
Different oligomeric state
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
159–272(114 aa)
|
Not recorded
|
No recorded non-water small molecule
|
SOLUTION NMR
NMR measurement conditions
pH 6.5;298 K;Ionic strength (raw mmCIF value) 70;Pressure 1
NMR sample composition
380 uM [U-13C; U-15N] FOXO1 DBD, 20 mM sodium phosphate, 50 mM potassium chloride, 2 mM TCEP, 100 % n/a n/a, 90% H2O/10% D2O | 90% H2O/10% D2O
|
Resolution not provided
|
|
6QZR
14-3-3 sigma in complex with FOXO1 pT24 peptide
Deposited 2019-03-12
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 4
PDB declaration: tetrameric
|
Chain N
19–29(11 aa)
Chain O
19–29(11 aa)
|
Non-standard monomer:Yes (specific site not provided by mmCIF)
Non-standard monomer:Yes (specific site not provided by mmCIF)
|
B3P 2-[3-(2-HYDROXY-1,1-DIHYDROXYMETHYL-ETHYLAMINO)-PROPYLAMINO]-2-HYDROXYMETHYL-PROPANE-1,3-DIOL × 1
GOL GLYCEROL × 2
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;pH 7;277 K;0.1M Bis-Tris propane pH 7, 0.2M Sodium nitrate, 28% (w/v) PEG400, 5% (w/v) glycerol
|
Resolution 2.30 Å
R-free 0.267
|
|
6QZR
14-3-3 sigma in complex with FOXO1 pT24 peptide
Deposited 2019-03-12
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 2
Protein heterocomplex
Heteromer;Protein × 4
PDB declaration: tetrameric
|
Chain M
19–29(11 aa)
Chain P
19–29(11 aa)
|
Non-standard monomer:Yes (specific site not provided by mmCIF)
Non-standard monomer:Yes (specific site not provided by mmCIF)
|
B3P 2-[3-(2-HYDROXY-1,1-DIHYDROXYMETHYL-ETHYLAMINO)-PROPYLAMINO]-2-HYDROXYMETHYL-PROPANE-1,3-DIOL × 1
GOL GLYCEROL × 2
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;pH 7;277 K;0.1M Bis-Tris propane pH 7, 0.2M Sodium nitrate, 28% (w/v) PEG400, 5% (w/v) glycerol
|
Resolution 2.30 Å
R-free 0.267
|
|
6QZR
14-3-3 sigma in complex with FOXO1 pT24 peptide
Deposited 2019-03-12
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 3
Protein heterocomplex
Heteromer;Protein × 4
PDB declaration: tetrameric
|
Chain J
19–29(11 aa)
Chain U
19–29(11 aa)
|
Non-standard monomer:Yes (specific site not provided by mmCIF)
Non-standard monomer:Yes (specific site not provided by mmCIF)
|
B3P 2-[3-(2-HYDROXY-1,1-DIHYDROXYMETHYL-ETHYLAMINO)-PROPYLAMINO]-2-HYDROXYMETHYL-PROPANE-1,3-DIOL × 1
GOL GLYCEROL × 2
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;pH 7;277 K;0.1M Bis-Tris propane pH 7, 0.2M Sodium nitrate, 28% (w/v) PEG400, 5% (w/v) glycerol
|
Resolution 2.30 Å
R-free 0.267
|
|
6QZR
14-3-3 sigma in complex with FOXO1 pT24 peptide
Deposited 2019-03-12
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 4
Protein heterocomplex
Heteromer;Protein × 4
PDB declaration: tetrameric
|
Chain R
19–29(11 aa)
Chain T
19–29(11 aa)
|
Non-standard monomer:Yes (specific site not provided by mmCIF)
Non-standard monomer:Yes (specific site not provided by mmCIF)
|
B3P 2-[3-(2-HYDROXY-1,1-DIHYDROXYMETHYL-ETHYLAMINO)-PROPYLAMINO]-2-HYDROXYMETHYL-PROPANE-1,3-DIOL × 1
GOL GLYCEROL × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;pH 7;277 K;0.1M Bis-Tris propane pH 7, 0.2M Sodium nitrate, 28% (w/v) PEG400, 5% (w/v) glycerol
|
Resolution 2.30 Å
R-free 0.267
|
|
8A62
Small molecule stabilizer (compound 2) for FOXO1 and 14-3-3
Deposited 2022-06-16
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 4
PDB declaration: tetrameric
|
Chain B
20–29(10 aa)
|
Non-standard monomer:Yes (specific site not provided by mmCIF)
|
MG MAGNESIUM ION × 4
L7L (3~{S})-1-[3,5-bis(chloranyl)-4-oxidanyl-phenyl]carbonyl-~{N}-[2-[2-(dimethylamino)ethyldisulfanyl]ethyl]piperidine-3-carboxamide × 2
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;277 K;0.095 M HEPES pH 7.5, 0.19 M CaCl2, 5% glycerol, 24% PEG 400
|
Resolution 1.60 Å
R-free 0.182
|
|
8A65
Small molecule stabilizer (compound 3) for FOXO1 and 14-3-3
Deposited 2022-06-16
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 4
PDB declaration: tetrameric
|
Chain B
21–28(8 aa)
|
Non-standard monomer:Yes (specific site not provided by mmCIF)
|
MG MAGNESIUM ION × 4
L70 (3~{S})-1-[2-azanyl-3,5-bis(chloranyl)phenyl]carbonyl-~{N}-[2-[2-(dimethylamino)ethyldisulfanyl]ethyl]piperidine-3-carboxamide × 2
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;277 K;0.095 M HEPES pH 7.3,
0.19 M CaCl2, 5% glycerol, 25% PEG 400
|
Resolution 1.60 Å
R-free 0.193
|